丹麦减肥药制造商诺和诺德周三公布第三季度营业利润符合预期,并缩小了全年销售额和利润指导区间。该公司表示,目前预计今年以本币计算的销售额增幅在23%至27%之间,而此前的指导区间为22%至28%。按本币计算,今年的营业利润增幅预计在21%至27%之间,而此前的预期为20%至28%。自今年年初以来,诺和诺德已经两次上调了2024年的销售增长预期。然而,今年8月,该公司下调了对营业利润增长的预期。该公司...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.